Blocking Plasmodium falciparum malaria transmission with drugs: The gametocytocidal and sporontocidal properties of current and prospective antimalarials

Pharmaceuticals

Volumn 4, Issue 1, 2011, Pages 44-68

  Kiszewski, Anthony E ^a  

^a BENTLEY UNIVERSITY   (United States)

Author keywords

Antimalarials; Gametocyte; Plasmodium; Sporogony; Transmission blocking

Indexed keywords

8 AMINOQUINOLINE DERIVATIVE; 9 ANILINOACRIDINE DERIVATIVE; AMODIAQUINE; ANTIMALARIAL AGENT; ARTEETHER; ARTELINIC ACID; ARTEMISININ DERIVATIVE; ARTESUNATE; ATOVAQUONE; AZADIRACHTA INDICA EXTRACT; AZADIRACHTIN; CHLOROQUINE; CYCLIC GMP; DYHYDROACRIDINE DIONE; EPOXOMICIN; INTERCELLULAR ADHESION MOLECULE 1; LIMONOID; METHYLENE BLUE; NEEMAZAL; PA 1103; PEROXIREDOXIN; PRIMAQUINE; PROTEIN KINASE; PROTEINASE; PYRAMAX; RIBOFLAVIN; SAR 116242; TAFENOQUINE; THROMBOSPONDIN; TIPRANAVIR; TRIOXAQUINE 2; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; WR 250547;

DRUG EFFECT; DRUG HALF LIFE; DRUG RESEARCH; GAMETOCYTE; HUMAN; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; METABOLIC INHIBITION; NONHUMAN; PARASITE DEVELOPMENT; PLASMODIUM BERGHEI INFECTION; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX MALARIA; PROTEIN TARGETING; REVIEW; SINGLE DRUG DOSE; TRANSCRIPTOMICS;

EID: 79551610458     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph4010044     Document Type: Review

References (139)

1. Vogel, G. The 'Do Unto Others' malaria vaccine. Science 2010, 328, 847-848.
2. Smalley, M.E.; Sinden, R.E. Plasmodium falciparum gametocytes: their longevity and infectivity. Parasitology 1977, 74, 1-8.
3. Butcher, G.A. Antimalarial drugs and the mosquito transmission of Plasmodium. Int. J. Parasitol. 1997, 27, 975-987.
4. Shigidi, M.M.T.; Hashim, R.A.; Idris, M.N.A.; Mukhtar, M.M.; Sokrab, T-E.O. Parasite diversity in adult patrients with cerebral malaria: a hospital-based, case-control study. Am. J. Trop. Med. Hyg. 2004, 71, 754-757.
5. Smith, T.G.; Lourenco, P.; Carter, R.; Walliker, D.; Ranford-Cartwright, L.C. Commitment to sexual differentiation in the human malaria parasite Plasmodium falciparum. Parasitology 2000, 121, 127-133.
6. Silvestrini, F.; Alano, P.; Williams, J.L. Commitment to the production of male and female gametocytes in the human malaria parasite Plasmodium falciparum. Parasitology 2000, 121, 465-471.
7. Carter, R.; Gwadz, R.W. Infectiousness and gamete immunization in malaria. In Malaria, Volume 3, Immunology and Immunization. Kreier, J.P., Ed.; Academic Press: New York, NY USA, 1980; pp. 263-298.
8. Eichner, M.; Diebner, H.H.; Molineaux, L.; Collins, W.E.; Jeffery, G.M.; Dietz, K. Genesis, sequestration and survival of Plasmodium falciparum gametocytes: parameter estimates from fitting a model to malariatherapy data. Trans. R. Soc. Trop. Med. Hyg. 2001, 95, 497-501.
9. Sinden, R.E. The cell biology of sexual development in Plasmodium. In Symposia of the British Society for Parasitology: The Reproductive Biology of Parasites; Whitfield, P.J., Ed. Published as Parasitology 86, Part 4, 1983; Volume 20, pp. 7-28.
10. Bousema, T.; Okell, L.; Shekalaghe, S.; Griffin, J.T.; Omar, S.; Sawa, P.; Sutherland, C.; Sauerwein, R.; Ghani, A.C.; Drakeley, C. Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malaria J. 2010, 9, 136.
11. Nassir, E.; Abdel-Muhsin, A.M.; Suliaman, S.; Kenyon, F.; Kheir, A.; Geha, H.; Ferguson, H.M.; Walliker, D.; Babiker, H.A. Impact of genetic complexity on longevity and gametocytogenesis of Plasmodium falciparum during the dry and transmission-free season of eastern Sudan. Int. J. Parasitol. 2005, 35, 49-55.
12. Field, J.W.; Shute, P.G. The microscopic diagnosis of human malaria. In A Morphological Study of the Eryhthrocytic Parasites; Government Press: Kuala Lumpur, Malaysia, 1956; p. 142.
13. Hawking, F.; Wilson, M.E.; Gammage, K. Evidence for cyclic development and short-lived maturity in the gametocytes of Plasmodium falciparum. Trans. Roy. Soc. Trop. Med. Hyg. 1971, 65, 549-559.
14. Carter, R.; Miller, L.H. Evidence for environmental modulation of gamtocytogenesis in Plasmodium falciparum in continuous culture. Bull. WHO 1979, 57, 37-52.
15. Sinden, R.E.; Smalley, M.E. Gametocytogenesis of Plasmodium falciparum in vitro: the cell cycle. Parasitology 1979, 79, 277-296.
16. Pandey, A.V.; Tekwani, R.L.; Singh, R.L.; Chauhan, V.S. Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification mechanisms in malarial parasites. J. Biol. Chem. 1999, 274, 19393-19388.
17. Schlesinger, P.H.; Krogstad, D.J.; Herwaldt, B.L. Antimalarial agents: mechanisms of action. Antimicrob. Agents Chemother. 1988, 32, 793-798.
18. Tekwani, B.L.; Walker, L.A. 8-Aminoquinolines: future role as antiprotozoal drugs. Curr. Opin. Infect. Dis. 2006, 19, 623-631.
19. Hill, D.R.; Baird, J.K.; Parise, M.E.; Lewis, L.S.; Ryan, E.T.; Magill, A.J. Primaquine: Report from CDC expert meeting on malaria chemoprophylaxis 1. Am. J. Trop. Med. Hyg. 2006, 75, 402-415.
20. Rieckmann, K.H.; McNamara, J.V.; Frischer, H.; Stockert, T.A.; Carson, P.E.; Powell, R.D. Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum. Bull. WHO 1968, 38, 625-632.
21. Coleman, R.E.; Clavin, A.M.; Schneider, I.; Song, G-H.; Klein, T.A.; Milhous, W.K. Transmission-blocking antimalarials prevent sporogony of Plasmodium falciparum and P. berghei in Anopheles stephensi mosquitoes. Am. J. Trop. Med. Hyg. 1994, 50, 646-653.
22. Smalley, M.E.; Sinden, R.E. Plasmodium falciparum gametocytes: their longevity and infectivity. Parasitology 1977, 74, 1-8.
23. Portela, M.J.; Moreira, R.; Valente, E.; Constantino, L.; Iley, J.; Pinto, J.; Rosa, R.; Cravo, P.; do Rosario, V.E. Dipeptide derivatives of primaquine as transmission-blocking antimalarials: the effect of aliphatic side-chain acylation on the gametocytocidal activity and on the formation of carboxyprimaquine in rat liver homogenates. Pharm. Res. 1999, 16, 949-955.
24. Bates, M.D.; Meshnick, S.R.; Sigler, C.I.; Leland, P.; Hollingdale, M.R. In vitro effects of primaquine and primaquine metabolites on exoerythrocytic stages of Plasmodium berghei. Am. J. Trop. Med. Hyg. 1990, 42, 532-537.
25. Wilairatana, P.; Krudsood, S.; Tangpukdee, N. Appropriate time for primaquine treatment to reduce Plasmodium falciparum transmission in hypoendendemic areas. Korean J. Parasitol. 2010, 48, 179-182.
26. Vale, N.; Moreira, R.; Gomes, P. Primaquine revisited six decades after its discovery. Eur. J. Med. Chem. 2009, 44, 937-953.
27. Bolchoz, L.J.C.; Budinsky, R.A.; McMillan, D.C.; Jollow, D.J. Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8- hydroxylaminoquinoline. J. Pharm. Exper. Therap. 2001, 297, 509-515.
28. Baird, J.K.; Surjadjaja, C.; Consideration of ethics in primaquine therapy against malaria transmission. Trends Parasitol. 2010, doi:10.1016/j.pt.2010.08.005.
29. Pukrittayakamee, S.; Chotivanich, K.; Chantra, A.; Clemens, R.; Looareesuwan, S.; White, N.J. Activities of artesunate and primaquine against asexual and sexual stage parasites in falciparum malaria. Antimicrob. Agents 2004, 48, 1329-1334.
30. White, N.J. The role of antimalarial drugs in eliminating malaria. Malaria J. 2008, 7, S8.
31. Kumar, N.; Zheng, H. Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum. Parasitol. Res. 1990, 76, 214-218.
32. Chotivanich, K.; Sattabongkot, J.; Udomsangpetch, R.; Looareesuwan, S.; Day, N.P.J.; Coleman, R.E.; White, N.J. Transmission-blocking activities of quinine, primaquine, and artesunate. Antimicrob. Agents Chemother. 2006, 50, 1927-1930.
33. Targett, G.; Drakely, C.; Jawara, M.; von Seidlein, L.; Coleman, R.; Deen, J.; Pinder, M.; Doherty, T.; Sutherland, C.; Walraven, G.; Milligan, P. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J. Infect. Dis. 2001, 183, 1254-1259.
34. Kurth, F.; Pongratz, P.; Belard, S.; Mordmuller, B.; Kremsner, P.G.; Ramharter, M. In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of antimalarial drug susceptibility assays. Malaria J. 2009, 8, 79.
35. Chavalitshewinkoon-Petmitr, P.; Pongvilairat, G.; Auparakkitanon, S.; Wilairat, P. Gametocytocidal activity of pyronaridine and DNA topoisomerase II inhibitors against multidrugresistant Plasmodium falciparum in vitro. Parasitol Int. 2000, 48, 275-280.
36. Ringwald, P.; Meche, F.S.; Basco, L.K. Short report: effects of pyronaridine on gametocytes in patients with acute uncomplicated falciparum malaria. Am. J. Trop. Med. Hyg. 1999, 61, 446-448.
37. Nosten, F.H. Pyronaridine-artesunate for uncomplicated falciparum malaria. Lancet 2010, 375, 1413-1414.
38. Olliaro, P.; Wells, T.N.C. The global portfolio of new antimalarial medicines under development. Clin. Pharm. Therap. 2009, 85, 584-595.
39. Wells, T.N.C.; Alonso, P.L.; Gutteridge, W.E. New medicines to improve control and contribute to the eradication of malaria. Nat. Rev. Drug Dis. 2009, 8, 879-891.
40. Brueckner, R.P.; Lasseter, K.C.; Lin, E.T.; Schuster, B.G. 1998. First-time-in-humans safety and pharmacokinetics of WR-238605, a new antimalarial. Am. J. Trop. Med. Hyg. 1998, 58, 645-659.
41. Crockett, M.; Kain, K.C. Tafenoquine: a promising new antimalarial agent. Expert Opin. Investig. Drugs 2007, 16, 705-715.
42. Coleman, R.E.; Ponsa, N.; Eikarat, N.; Kollars, T.M. Jr.; Sattabongkot, J. Prevention of sporogony of Plasmodium vivax in Anopheles dirus mosquitoes by transmission-blocking antimalarials. Am. J. Trop. Med. Hyg. 2001, 65, 214-218.
43. Ponsa, N.; Sattabongkot, J.; Kittayapong, P.; Eikarat, N.; Coleman, R.E. Transmission-blocking activity of tafenoquine (WR-2386605) and artelinic acid against naturally circulating strains of Plasmodium vivax in Thailand. Am. J. Trop. Med. Hyg. 2003, 69, 542-547.
44. Puri, S.K.; Dutta, G.P. Plasmodium cynomolgi: gametocytocidal activity of the anti-malarial compound CDRI 80/53 (elubaquine) in rhesus monkeys. Exp. Parasitol. 2005, 111, 8-13.
45. Krudsood, S.; Wilairatana, P.; Tangpukdee, N.; Chalermut, K.; Srivilairit, S.; Thanachartwet, V.; Muangnoicharoen, S.; Luplertlop, N.; Brittenham, G.M.; Looareesuwan, S. Safety and tolerability of elubaquine (Bulaquine, CDRI 80/53) for treatment of Plasmodium vivax malaria in Thailand. Korean J. Parasitol. 2006, 44, 221-228.
46. Gogtay, N.J.; Kamtekar, K.D.; Dalvi, S.S.; Chogle, A.R.; Aigal, U.; Kshirsagar, N.A. Preliminary report of the evaluation of the gametocytocidal action of bulaquine, in adult patients with acute, Plasmodium falciparum malaria. Ann. Trop. Med. Parasitol. 2004, 98, 525-528.
47. Dechy-Cabaret, O.; Benoit-Vical, F.; Loup, C.; Robert, A.; Gornitzka, H.; Bonhoure, A.; Vial, H.; Magnaval, J-F.; Séguéla, J-P.; Meunier, B. Synthesis and antimalarial activity of trioxaquine derivatives. Chem. Eur. J. 2004, 10, 1625-1636.
48. Coslédan, F.; Fraisse, L.; Pellet, A.; Guillou, F.; Mordmüller, B.; Kremsner, P.G.; Moreno, A.; Mazier, D.; Maffrand, J-P.; Meunier, B. Selection of a trioxaquine as an antimalarial drug candidate. Proc. Nat. Acad. Sci.USA 2008, 105, 17579-17584.
49. Benoit-Vical, F.; Leleivre, J.; Berry, A.; Deymier, C.; Dechy-Cabaret, O.; Cazelles, J.; Loup, C.; Robert, A.; Magnaval, J-F.; Meunier, B. Trioxaquines are new antimalarial agents active on all erythrocytic forms including gametocytes. Antimicrob. Agents Chemother. 2007, 51, 1463-1472.
50. Hanada, M.; Sugawara, K.; Kaneta, K.; Toda, S.; Nishiyama, Y.; Tomita, K.; Yamamoto, H.; Konishi, M.; Oki, T. Epoxomicin, a new antitumor agent of microbial origin. J. Antibiot. (Tokyo) 1992, 45, 1746-1752.
51. Katukojvala, S.; Barlett, K.N.; Lotesta, S.D., Williams, L.J. Spirodiepoxides in total synthesis: epoxomicin. J. Am. Chem. Soc. 2004, 126, 15348-15349.
52. Czesny, B.; Goshu, S.; Cook, J.L.; Williamson, K.C. The proteasome inhibitor epoxomicin has potent Plasmodium falciparum gametocytocidal activity. Antimicrob. Agents Chemother. 2009, 53, 4080-4085.
53. Guttmann P.; Ehrlich, P. Über die Wirkung des Methylenblau bei Malaria. Berliner Klinische Wochenschrift 1891, 39, 953-956.
54. Schirmer, R.H.; Coulibaly, B.; Stich, A.; Scheiwein, M.; Merkle, H.; Eubel, J.; Becker, K.; Becher, H.; Müller, O.; Zich, T.; Schiek, W.; Kouyaté, B. Methylene blue as an antimalarial agent. Redox Rep. 2003, 8, 272-275.
55. Coulibaly, B.; Zoungrana, A.; Mockenhaupt, F.P.; Schirmer, R.H.; Klose, C.; Mansmann, U.; Meissner, P.E.; Muller, O. Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomized controlled trial. PLOS One 2009, 4, e5318.
56. Tripathi, R.; Dutta, G.P.; Vishwakarma, R.A. Gametocytocidal activity of alpha/beta arteether by the oral route of administration. Am. J. Trop. Med. Hyg. 1996, 54, 652-654.
57. Pareek, A.; Nandy, A.; Kochar, D.; Patel, K.H.; Mishra, S.K.; Mathur, P.C. Efficacy and safety of beta-arteether and alpha/beta-arteether for treatment of acute Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 2006, 75, 139-142.
58. Tripathi, R.; Dutta, G.P.; Vishwakarma, R.A. Gametocytocidal activity of the antimalarial alpha/beta arteether against Plasmodium cynomolgi B. Am. J. Trop. Med. Hyg. 1990, 43, 571-575.
59. Peatey, C.L.; Andrews, K.T.; Eickel, N.; MacDonald, T.; Butterworth, A.S.; Trenholme, K.R.; Gardiner, D.L.; McCarthy, J.S.; Skinner-Adams, T.S. Antimalarial asexual stage-specific and gametocytocidal activities of HIV protease inhibitors. Antimicrob. Agents Chemother. 2010, 54, 1334-1337.
60. Schneider, E.; Hsiang, Y-H.; Liu, L.F. DNA topoisomerases as anticancer drug targets. 1991. Adv. Pharmacol. 21, 149-183.
61. Auparakkitanon, S.; Noonpakdee, W.; Ralph, R.K.; Denny, W.A.; Wilairat, P. Antimalarial 9- anilinoacridine compounds directed at hematin. Antimicrob. Agents Chemother. 2003, 47, 3708-3712.
62. Chavalitshewinkoon-Petmitr, P.; Pongvilairat, G.; Ralph, R.K.; Denny, W.A.; Wilairat, P. Inhibitory effects of 9-aniloacridines on Plasmodium falciparum gametocytes. Trop. Med. Int. Health. 2001, 6, 42-45.
63. Akompong, T.; Eksi, S.; Williamson, K.; Haldar, K. Gametocytocidal activity and synergistic interactions of riboflavin with standard antimalarial drugs against growth of Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 2000, 44, 3107-3111.
64. Okumu, F.O.; Knols, B.G.J.; Filinger, U. Larvicidal effects of a neem (Azadirachta indica) oil formulation on the malaria vector Anopheles gambiae. Malaria J. 2007, 6, 63.
65. Jones, I.W.; Denholm, A.A.; Ley, S.V.; Lovell, H.; Wood, A.; Sinden, R.E. 1994. Sexual development of malaria parasites is inhibited in vitro by the Neem extract Azadirachtin, and its semi-synthetic analogues. FEMS Microbiol. Lett. 1994, 120, 267-273.
66. Bray D.H.; Warhurst, D.C.; Connolly, J.D.; O'Neill, M.J.; Phillipson, J.D. Plants as sources of antimalarial drugs. Part 7. Activity of some species of Meliacae plants and their constituent limonoids. Phytother. Res. 1990, 4, 29-35.
67. Lucantoni, L.; Yerbanga, R.S.; Lupidi, G.; Pasqualini, L.; Esposito, F.; Habluetzel, A. Transmission blocking activity of a standardized neem (Azadirachta indica) seed extract on the rodent malaria parasite Plasmodium berghei in its vector Anopheles stephensi. Malaria J. 2010, 9, 66.
68. Udeinya, I.J.; Brown, N.; Shu, E.N.; Udeinya, F.I.; Quakyi, I. Fractions of an antimalarial neemleaf extract have activities superior to chloroquine, and are gametocytocidal. Ann. Trop. Med. Parasitol. 2006, 100, 17-22.
69. Udeinya, I.J.; Shu, E.N.; Quakyi, I.; Ajaya, F.O. An antimalarial neem leaf extract has both schizonticidal and gametocytocidal activities. Am. J. Ther. 2008, 15, 108-110.
70. Billker, O.; Shaw, M.K.; Jones, I.W.; Ley, S.V.; Mordue, A.J.; Sinden, R.E. Azadirachtin disrupts formation of organized microtubule arrays during microgametogenesis of Plasmodium berghei. J. Eukaryot. Microbiol. 2002, 49, 489-497.
71. Manners, G.D.; Jacob, R.A.; Breksa, A.P. III; Schoch, T.K.; Hasegawa, S. Bioavailability of citrus limonoids in humans. J. Agric. Food Chem. 2003, 51, 4156-4161.
72. Omar, S.; Zhang, J.; MacKinnon, S.; Leaman, D.; Durst, T.; Philogene, B.J.; Arnason, J.T.; Sanchez-Vindas, P.E.; Poveda, L.; Tamez, P.A.; Pezzuto, J.M. Traditionally-used antimalarials from the Meliaceae. Curr. Top. Med. Chem. 2003, 3, 133-139.
73. Rener, J.; Graves, P.M.; Carter, R.; Williams, J.L.; Burkot, T.R. Target antigens of transmission blocking immunity on gametes of Plasmodium falciparum. J. Exp. Med. 1983, 158, 976-981.
74. Vermeulen, A.N.; Ponnudurai, T.; Beckers, P.J.A.; Verhave, J.P.; Smits, M.A.; Meuwissen, J.H. Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission blocking antibodies in the mosquito. J. Exp. Med. 1985, 162, 1460-1476.
75. Quakyi, I.A.; Carter, R.; Rener, J.; Kumar, N.; Good, M.F.; Miller, L.H. The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies. J. Immunol. 1987, 139, 4213-4217.
76. Eksi, S.; Czesny, B.; van Gemert, G.J.; Sauerwein, R.W.; Eling, W.; Williamson, K.C. Malaria transmission-blocking antigen, Pfs230, mediates human red blood cell binding to exflagellating male parasites and oocyst production. Mol. Microbiol. 2006, 61, 991-998.
77. Torres, J.A.; Rodriguez, M.H.; Rodriguez, M.C.; Hernandez-Hernandex, F. Plasmodium berghei: Effect of protease inhibitors during gametogenesis and early zygote development. Exp. Parasitol. 2005, 111, 255-259.
78. Nielsen, K.M.; Kasper, J.; Choi, M.; Bedford, T.; Kristiansen, K.; Wirth, D.F.; Volkman, S.K.; Lozofsky, E.R.; Hartl, D.L. Gene conversion as a source of nucleotide diversity in Plasmodium falciparum. Mol. Biol. Evol. 2003, 20, 726-734.
79. Rosenthal, P.J.; Sijwali, P.S.; Singh, A.; Shenai, B.R. Cysteine proteases of malaria parasites: targets for chemotherapy. Curr. Pharm. Des. 2002, 8, 1659-1672.
80. Shenai, B.R.; Sijwali, P.S.; Singh, A.; Rosenthal, P.J. Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum. J. Biol. Chem. 2000, 275, 29000-29010.
81. Sijwali, P.S.; Shenai, P.R.; Gut, J.; Singh, A.; Rosenthal, P.J. Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3. Biochem. J. 2001, 360, 481-489.
82. Eksi, S.; Czesny, B.; van Gemert, G.-J.; Sauerwein, R.W.; Eling, W.; Williamson, K.C. Inhibition of Plasmodium falciparum oocyst production by membrane-permeant cysteine protease inhibitor E64d. Antimicrob. Agents Chemother. 2007, 51, 1064-1070.
83. O'Connell, M.J.; Krien, M.J.; Hunter, T. Never say never. The NIMA-related protein kinases in mitotic control. Trends Cell. Biol. 2003, 13, 221-228.
84. Graeser, R.; Kury, P.; Franklin, R.M.; Kappes, B. Characterization of a mitogen-activated protein (MAP) kinase from Plasmodium falciparum. Mol. Microbiol. 1997, 23, 151-159.
85. Dorin, D.; Alano, P.; Boccaccio, I.; Ciceron, L.; Doerig, C.; Sulpice, R.; Parzy, D.; Doerig, C. An atypical mitogen-activated protein kinase (MAPK) homologue expressed in gametocytes of the human malaria parasite Plasmodium falciparum. Identification of a MAPK signature. J. Biol. Chem. 1999, 274, 29912-29920.
86. Rangarajan, R.; Bei, A.K.; Jethwaney, D.; Maldonado, P.; Dorin, D.; Sultan, A.A.; Doerig, C. A mitogen-activated protein kinase regulates male gametogenesis and transmission of the malaria parasite Plasmodium berghei. EMBO Rep. 2005, 6, 464-469.
87. Khan, S.M.; Franke-Fayard, B.; Mair, G.R.; Lasonder, E.; Janse, C.J.; Mann, M.; Waters, A.P. Proteome analysis of separated male and female gametocytes reveals novel sex-specific Plasmodium biology. Cell 2005, 121, 675-687.
88. Reininger, L.; Tewari, R.; Fennell, C.; Holland, Z.; Goldring, D.; Ranford-Cartwright, L.; Billker, O.; Doerig, C. An essential role for the Plasmodium Nek-2 Nima-related protein kinase in the sexual development of malaria parasites. J. Biol. Chem. 2009, 31, 20858-20868.
89. Lye, Y.M.; Chan, M.; Sim, T-S. Pfnek3: an atypical activator of a MAP kinase in Plasmodium falciparum. FEBS Lett. 2006, 580, 6083-6092.
90. Reininger, L.; Billker, O.; Tewari, R.; Mukhopadhyay, A.; Fennell, C.; Dorin-Semblat, D.; Doerig, C.; Goldring, D.; Harmse, L.; Ranford-Cartwright, L.; Packer, J.; Doerig, C. A NIMArelated protein kinase is essential for completion of the sexual cycle of malaria parasites. J. Biol. Chem. 2005, 280, 31957-31964.
91. Billker, O.; Dechamps, S.; Tewari, R.; Wenig, G.; Franke-Fayard, B.; Brinkmann, V. Calcium and a calcium-dependent protein kinase regulate gamete formation and mosquito transmission in a malaria parasite. Cell 2004, 117, 503-514.
92. Khan, S.M.; Franke-Fayard, B.; Mair, G.R.; Lasonder, E.; Janse, C.J.; Mann, M.; Waters, A.P. Proteome analysis of separated male and female gametocytes reveals novel sex-specific Plasmodium biology. Cell 2005, 121, 675-687.
93. Veal, E.A.; Findlay V.J.; Day, A.M.; Bozonet, S.M.; Evans, J.M.; Quinn, J.; Morgan, B.A. 2004. A 2-Cys peroxiredoxin regulates peroxide-induced oxidation and activation of a stress-activated MAP kinase. Mol. Cell. 2004, 15, 129-139.
94. Yano, K.; Komaki-Yasuda, K.; Tsuboi, T.; Torii, M.; Kano, S.; Kawazu. 2-Cys Peroxiredoxin TPx-1 is involved in gametocyte development in Plasmodium berghei. Mol. Biochem. Parasitol. 2006, 148, 44-51.
95. Kawamoto, F.; Alejo-Blanco, R.; Fleck, S.L.; Kawamoto, Y.; Sinden, R.E. Possible roles of Ca2+ and cGMP as mediators of the exflagellation of Plasmodium berghei and Plasmodium falciparum. Mol. Biochem. Parasitol. 1990, 42, 101-108.
96. Taylor, C.J.; McRobert, L.; Baker, D.A. Disruption of a Plasmodium falciparum cyclic nucleotide phosphodiesterase gene causes aberrant gametogenesis. Mol. Microbiol. 2008, 69, 110-118.
97. Rudzinska, M.A.; Trager, W. The fine structure of trophozoites and gametocytes in Plasmodium coatneyi. J. Protozool. 1968, 15, 73-88.
98. Sinden, R.E. Gametocytogenesis of Plasmodium falciparum in vitro: an electron microscopic study. Parasitology 1982, 84, 1-11.
99. de Koning-Ward, T.; Olivieri, A.; Bertuccini, L.; Hood, A.; Silvestrini, F.; Charvalias, K.; Diaz, P.B.; Camarda, G.; McElwain, T.F.; Papemfuss, T.; Healer, J.; Baldassarri, L.; Crabb, B.S.; Alanp, P.; Ranford-Cartwright, L.C. Mol. Microbiol. 2008, 67, 279-290.
100. Scherf, A.; Carter, R.; Petersen, C.; Alano, P.; Nelson, R.; Aikawa, M.; Mattei, D.; Pereira da Silva, L.; Leech, J. Gene inactivation of Pf11-1 of Plasmodium falciparum by chromosome breakage and healing: identification of a gametocyte-specific protein with a potential role in gametogenesis. EMBO J. 1992, 11, 2293-2301.
101. Florens, L.; Washburn, M.P.; Raine, J.D.; Anthony, R.M.; Grainger, M.; Haynes, J.D.; Moch, J.K.; Muster, N.; Sacci, J.B.; Tabb, D.L. et al. A proteomic view of the Plasmodium falciparum life cycle. Nature 2002, 419, 520-526.
102. Silvestrini, F.; Bozdech, Z.; Lanfrancotti, A.; Di Giulio, E.; Bultrini, E.; Picci, L.; deRisi, J.J.; Pizzi, E.; Alano, P. Genome-wide identification of genes upregulated at the onset of gametocytogenesis in Plasmodium falciparum. Mol. Biochem. Parasitol. 2005, 143, 100-110.
103. Bruce, M.C.; Carter, R.N.; Nakamura, K.; Aikawa, M., Carter, R. Cellular location and temporal expression of the Plasmodium falciparum sexual stage antigen Pfs16. Mol. Biochem. Parasitol. 1994, 65, 11-22.
104. Baker, D.A.; Daramola, O.; McCrossan, M.V.; Harmer, J.; Targett, G.A. Subcellular localization of Pfs16, a Plasmodium falciparum gametocyte antigen. Parasitology 1994, 108, 129-137.
105. Berry, A.; Deymier, C.; Sertorio, M.; Witkowski, B.; Benoit-Vical, F.; Pfs 16 pivotal role in Plasmodium falciparum gametocytogenesis: a potential antiplasmodial drug target. Exp. Parasitol. 2009, 121, 189-192.
106. Lobo, C.A.; Fujioka, H.; Aikawa, M.; Kumar, N. Disruption of the Pfg27 locus by homologous recombination leads to loss of the sexual phenotype in Plasmodium falciparum. Mol. Cell. 1999, 3, 793-798.
107. Furuya, T.; Mu, J.; Hayton, K.; Liu, A.; Duan, J.; Nkrumah, L.; Joy, D.A.; Fidock, D.A.; Fujioka, H.; Vaidya, A.B.; Wellems, T.E.; Su, X. Disruption of Plasmodium falciparum gene linked to male sexual development causes early arrest in gametocytogenesis. Proc. Nat. Acad. Sci. USA 2005, 46, 16813-16818.
108. Cui, L.; Fan, Q.; Li, J. The malaria parasite Plasmodium falciparum encodes members of the Puf RNA-binding protein family with conserved RNA binding activity. Nucleic Acids Res. 2002, 30, 4607-4617.
109. Miao, J.; Li, J.; Fan, Q.; Li, X.; Li, X.; Cui, L. The Puf-family RNA-binding protein PfPuf2 regulates sexual development and sex differentiation in the malaria parasite Plasmodium falciparum. J. Cell Sci. 2010, 123, 1039-1049.
110. Gardiner, D.L.; Dixon, M.W.; Spielmann, T.; Skinner-Adams, T.S.; Hawthorne, P.L.; Ortega, M.R.; Kemp, D.J.; Trenholme, K.R. Implication of a Plasmodium falciparum gene in the switch between asexual reproduction and gametocytogenesis. Mol. Biochem. Parasitol. 2005, 140, 153-160.
111. Gissot, M.; Ting, L-M.; Daly, T.M.; Bergman, L.W.; Sinnis, P.; Kim, K. High mobility group protein HMGB2 is a critical regulator of Plasmodium oocyst development. J. Biol. Chem. 2008, 283, 17030-17038.
112. Eksi, S.; Haile, Y.; Furuya, T.; Ma, L.; Su, X.; Williamson, K.C. Identification of a subtelomeric gene family expressed during the asexual-sexual stage transition in Plasmodium falciparum. Mol. Biochem. Parasitol. 2005, 143, 90-99.
113. Silvestrini, F.; Lasonder, E.; Olivieri, A.; Camarda, G.; van Schaijk, B.; Sanchez, M.; Younis, S.; Sauerwein, R.; Alano, P. Protein export marks the early phase of gametocytogenesis of the human malaria parasite Plasmodium falciparum. Mol. Cell. Proteomics 2010, 9, 1437-1448.
114. Matuschewski, K.; Ross, J.; Brown, S.M.; Kaiser, K.; Nussenzweig, V.; Kappe, S.H.I. Infectivity-associated changes in the transcriptional repertoire of the malaria parasite sporozoite stage. J. Biol. Chem. 2002, 277, 41948-41953.
115. Sutherland, C.J. Surface antigens of Plasmodium falciparum gametocytes - a new class of transmission-blocking vaccine targets? Mol. Biochem. Parasitol. 2009, 166, 93-98.
116. Sherman, I.W.; Eda, S.; Winograd, E. Cytoadherence and sequestration in Plasmodium falciparum: defining the ties that bind. Microb. Infect. 2003, 5, 897-909.
117. Baruch, D.I.; Gormely, J.A.; Ma, C.; Howard, R.J.; Pasloske, B.L. Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intracellular adhesion molecule 1. Proc. Nat. Acad. Sci. USA 1996, 93, 3497-3502.
118. Talman, A.M.; Domarle, O.; McKenzie, F.E.; Arey, F.; Robert, V. Gametocytogenesis: the puberty of Plasmodium falciparum. Malaria J. 2004, 3, 24.
119. Piper, K.P.; Hayward, R.E.; Cox, M.J.; Day, K.P. Malaria Transmission and Naturally Acquired Immunity to PfEMP-1. Infec. Immunity 1999, 67, 6369-6374.
120. Wang, C.W.; Mwakalinga, S.B.; Sutherland, C.J.; Schwank, S.; Sharp, S.; Hermsen, C.C.; Sauerwein, R.W.; Theander, T.G.; Lavstsen, T. Identification of a major rif transcript common to gametocytes and sporozoites of Plasmodium falciparum. Malaria J. 2010, 9, 147.
121. Taylor, T.E.; Molyneux, M.; Wirima, J.; Borgstein, A.; Goldring, J.; Hommel, M. Intravenous immunoglobulin in the treatment of paediatric cerebral malaria. Clin. Exp. Immunol. 1992; 90, 357-362.
122. Goldring, J.P.D. Evaluation of immunotherapy to reverse sequestration in the treatment of severe Plasmodium falciparum malaria. Immunol. Cell Biol. 2004, 82, 447-452.
123. Bloemen, P.G.M.; Henricks, P.A.J.; van Bloois, L.; van den Tweel, M.C.; Bloem, A.C.; Nijkamp, F.P.; Crommelin, D.J.A.; Storm, G. Adhesion molecules: a new target for immunoliposomemediated drug delivery. FEBS Lett. 1995, 357, 140-144.
124. Claudianos, C.; Dessens, J.T.; Trueman, H.E.; Arai, M. Mendoza J.; et al. A malaria scavenger receptor-like protein essential for parasite development. Mol. Microbiol. 2002, 45, 1473-1484.
125. Raine, J.D.; Ecker, A.; Mendoza, J.; Tewari, R.; Stanway, R.R.; Sinden, R.E. PLoS Pathogens 2007, 3, e30.
126. Pradel, G.; Hayton, K.; Aravind, I.; Iyer, L.M.; Abrahamsen, M.S.; Bonawitz, A.; Meija, C.; Templeton, T.J. A multidomain adhesion protein family expressed in Plasmodium falciparum is essential for transmission to the mosquito. J. Exp. Med. 2004, 199, 1533-1544.
127. Scholz, S.M.; Simon, N.; Lavazec, C.; Dude, M-A.; Templeton, T.J.; Pradel, G. PfCCp proteins of Plasmodium falciparum: Gametocyte-specific expression and role in complement-mediated inhibition of exflagellation. Int. J. Parasitol. 2007, 38, 327-340.
128. Buckling, A.; Ranford-Cartwright, C.L.; Miles, A.; Read, A.F. Chloroquine increases Plasmodium falciparum gametocytogenesis in vivo. Parasitology 1999, 118, 339-346.
129. Robert, V.; Awono-Ambene, H.P.; Le Hesran, J.Y.; Trape, J.F. Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with choloroquine or sulfadoxine plus pyrimethamine. Am. J. Trop. Med. Hyg. 2000, 62, 210-216.
130. von Seidlein, L.; Drakely, C.; Greenwood, B.; Walraven, G.; Targett, G. Risk factors for gametocyte carriage in Gambian children. Am. J. Trop. Med. Hyg. 2001, 65, 523-527.
131. Dunyo, S.; Milligan, P.; Edwards, T.; Sutherland, C.; Targett, G.; Pinder, M. Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum. PLoS Clin. Trial. 2006, 194, e20.
132. Marks, F.; Evans, J.; Meyer, C.G.; Browne, E.N.; Flessner, C.; von Kalckreuth, V.; Eggelte, T.A.; Horstmann, R.D.; May, J. High prevalence of markers for sulfadoxine and pyrimethamine resistance in Plasmodium falciparum in the absence of drug pressure in the Ashanti region of Ghana. Antimicrob. Agents Chemother. 2005, 49, 1101-1105.
133. Prudhomme O'Meara, W.; Smith, D.L.; McKenzie, F.E. Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria. PLoS Med. 2006, 3, e141.
134. Dicko, A.; Sagara, I.; Djimde, A.; Toure, S.; Traore, M.; Dama, S.; Diallo, A.; Barry, A.; Dicko, M.; Coulibaly, O.; Rogier, C.; de Sousa, A.; Doumbo, O. Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali. Malaria J. 2010, 9, 9.
135. Kone, A.; van de Vegte-Bolmer, M.; Siebelink-Stoter, R.; van Gmert, G-J.; Dara, A.; Niangaly, H.; Luty, A.; Doumbo, O.K.; Sauerwein, R.; Djimde, A.A. Sulfadoxine-pyrimethamine impairs Plasmodium falciparum gametocyte infectivity and Anopheles mosquito survival. Int. J. Parasitol. 2010, 40, 1221-1228.
136. Beauvogui, A.H.; Djimde, A.A.; Gregson, A.; Toure, A.M.; Dao, A.; Coulibaly, B.; Ouologuem, D.; Fofana, B.; Sacko, A.; Tekete, M.; Kone, A.; Niare, O.; Wele, M.; Plowe, C.V.; Picot, S.; Doumbo, O.K. Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali. Int. J. Parasitol. 2010, 40, 1213-1220.
137. Zwang, J.; Ashley, E.A.; Karema, C.; D'Alessandro, U.; Smithuis, F.; Dorsey, G.; Janssens, B.; Mayxay, M.; Newton, P.; Singhasivanon, P.; Stepniewska, K.; White, N.J.; Nosten, F. Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis. PLoS One 2009, 4, e6358.
138. Hastings, I.M. Gametocytocidal activity in antimalarial drugs speeds the spread of drug resistance. Trop. Med. Int. Health 2006, 11, 1206-1217.
139. Okell, L.C.; Drakeley, C.J.; Bousema, T.; Whitty, C.J.; Ghani, A.C. Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. PLoS Med. 2008, 5, e226.